As spine leaders look ahead to 2026, enthusiasm around regenerative medicine and neuromodulation continues to build. But much of the conversation still flattens a field that is far more complex than it appears, according to Ann Parr, MD, PhD.
Dr. Parr is vice chair of research and a professor of neurosurgery at the Minneapolis-based University of Minnesota, where she also serves as director of spinal neurosurgery. She said one of the most persistent misconceptions is the idea that “spine” represents a single therapeutic problem and that advances in biologics or stimulation will rapidly replace surgery.
“I think one of the things that’s most misunderstood is the fact that all spine problems aren’t the same,” Dr. Parr told Becker’s…